Publish Date: September 2026
Updated Tariff & Recession Risk Analysis and Forecasts
The 2026 Biological Product Manufacturing Market Report covers the $81 billion industry which produces complex protein-based therapeutics, vaccines, and related products derived from living organisms rather than chemical synthesis. Competitive structure encompasses specialized biopharmaceutical companies alongside diversified pharmaceutical corporations with biologics divisions. Market requirements increasingly emphasize manufacturing process consistency, product characterization, regulatory compliance, and increasingly specialized delivery systems addressing administration challenges. Manufacturers face challenges balancing complex bioprocessing technologies, strict quality requirements, cold chain logistics, and tariff implications affecting both specialized material imports and international market access. Successful companies establish advantages through advanced bioprocessing technologies ensuring consistency, specialized characterization capabilities confirming biological activity, robust quality systems preventing contamination, and innovative delivery systems enhancing therapeutic outcomes in a highly specialized sector where manufacturing process control and quality assurance critically determine competitive positioning.
Biological Product Manufacturing Industry Description
Biological Product Manufacturing produces complex therapeutic proteins, vaccines, blood derivatives, and other biologically-derived health products. Companies utilize living organisms or their components to create large-molecule treatments through sophisticated biological processes. Manufacturing processes include cell culture, fermentation, purification through chromatography, filtration, viral inactivation, formulation, and aseptic filling operations conducted in highly controlled environments. These businesses serve healthcare providers with advanced therapeutic options. The industry represents a sophisticated manufacturing segment, continuously improving production yields, quality control, and increasingly focusing on cell and gene therapies, personalized biologics, and manufacturing technologies that advance treatment options for complex diseases.
NAICS Code: 325414
Number of Companies: 252
Number of Plants / Facilities: 330
Total Employees: 58,835
Market Size: $81 billion
TARIFF IMPACT (Summer 2025 – Download Report for Updated Analysis)
This report has in-depth analysis on the recent US tariff changes on material costs, quantifying import dependencies, tariff exposure rates, and key source countries for the biological product manufacturing sector.
Estimated Tariff Cost: $1.3 billion
Relative Tariff Impact: MODERATE
Biological Product Manufacturing Report Format
The 2026 U.S. Biological Product Manufacturing Market Report is 63 pages of deep insights into the trends, dynamics, and forecasts shaping the industry. This market report is utilized by professionals to gain a in-depth understanding of the sector for business strategy, planning, forecasting, benchmarking, industry analysis, valuations, identifying organizational inefficiencies, financial analysis, and more.
The report has over 100 industry statistical data sets with historicals (2017-2025), trend analysis, and forecasts for 2026 and the next 5 years. The report includes sales & expense trends, 26 expense categories, extensive financial analysis, extensive forecasts, inventory trends & analysis, 31 balance sheet benchmarks, company segmentation analysis, industry concentration analysis, material costs analysis, profitability metrics, state benchmarks, plant capacity analysis, workforce composition, inflation statistics, wage analysis, in-depth productivity analysis, and more.
Below are a few page images from the report and check out the table of contents for a complete overview.
Report Table of Contents
Review the table of contents to understand the comprehensive insights in the report and why thousands of professionals and executives count on Kentley Insights for their industry research.
For this report, the core data is sourced from comprehensive business, operational, and economic surveys conducted by government and private institutions and filled out by a statistically significant number of companies in the biological product manufacturing industry. Our forecasts take into account historical trends, industry dynamics, and our macroeconomic projections.
1-2 – Report Overview & Table of Contents
3 – Market Overview
– Methodology, Industry Definition & Market Commentary
4 – Market Snapshot – Revenue & Growth
5 – Market Snapshot – Costs & Profitability
SECTION ONE
REVENUE & GROWTH BENCHMARKS
7 – Market Growth Details
– Revenues, Companies, & Facilities
– 2017-2025 Historical Figures
– Forecasts for 2026 and the Next 5 Years
8 – Growth Benchmarks
– Revenues per Company & Facility
– Facilities per Company
– 2017-2025 Historical Figures
– Forecasts for 2026 and the Next 5 Years
9 – Breakdown of Product Lines
– Percentage of Revenue from Product Lines
10 – BCG Matrix – Net Income vs. Revenue Growth
– Manufacturing Subsectors vs. Industry
11 – Total Revenue by Month & Year
– Revenue per Month for 2021-2025
12 – Inventory Value by Month & Year
– Inventory Value per Month for 2021-2025
13 – Months of Inventory
– Months of Inventory per Month for 2021-2025
14 – Market Size by Segments
– Concentration Segments – Top 4, 5-8, 9-20, & 21-50 companies
– Business Size Segments – 1-4, 5-9, 10-20, 21-50, 51-100, 101-250, & 250+ employees
– Business Structure Segments – C-Corporations, S-Corporations, Partnerships, & Sole Proprietorships
15 – Market Size by State
16 – Revenue as a % of State GDP
17 – Revenue as a % of State Manufacturing
18 – Market Segmentation by Business Size
– Sales as a % of Income and State Rankings
19 – Market Segmentation by Business Size
– Business Size Segments – 1-4, 5-9, 10-20, 21-50, 51-100, 101-250, & 250+ employees
– Companies, Facilities, Sales, Employees & Payroll
20 – Segmentation by Concentration (Top 50 Companies)
– Concentration Segments – Top 4, 5-8, 9-20, & 21-50 companies
– Companies, Facilities, Sales, Employees & Payroll
21 – Market Share of Top 50 Companies
– Market Share & Total Revenue for 2020 versus 2025
22 – Subsector Market Share of Top 50 Companies
23 – Segmentation by Business Structure
– Business Structure Segments – C-Corporations, S-Corporations, Partnerships, & Sole Proprietorships
– Companies, Facilities, Sales, Employees & Payroll
24 – Sales per Company by State
25 – Sales per Company by Segments
26 – Sales per Facility by State
27 – Sales per Facility by Segment
28 – Manufacturing Subsector Growth
– Sales and 5-Year CAGR
29 – Manufacturing Subsector Statistics
– Sales per Company & Facility, and 5-Year CAGR
30 – Consolidation Analysis
– 5-year CAGR of Companies & Locations
31 – Employment Consolidation Analysis
– 5-year CAGR of Employee Statistics
32 – Manufacturing Subsector Consolidation Analysis
– Number of Companies & Facilities
– 5-Year CAGR
33 – Manufacturing Subsector Consolidation Analysis
– Facilities per Company
– Employees per Company
– 5-Year CAGR
SECTION TWO
COST, CAPITAL & PROFIT BENCHMARKS
35 – Profitability & Financial Ratio Analysis
– Percent of Companies that are Profitable
– Average Net Income as a Percent of Revenue
– Financial Ratios – 10 ratios, Total Asset Turnover, Fixed Asset Turnover, Fixed Assets to Total Assets Ratio, Total Assets to Total Liabilities Ratio, Return on Sales, Return on Total Assets, Return on Net Worth, Total Liabilities to Net Worth Ratio, Fixed Assets to Net Worth Ratio, Solvency Ratio
Page 36 – Balance Sheet Metrics
– Assets and Liabilities indexed to industry revenue at 100
– Current & Non-Current Assets: Cash, Notes & Accounts Receivable, Allowance for Bad Debts, Inventories, Treasuries & Securities, Other Current Assets, Loans to Shareholders / Mortgage, Other Investments, Depreciable Assets, Accumulated Depreciation, Land, Intangible Assets (Amortizable), Accumulated Amortization, Other Assets
– Short-term, Long-term Liabilities, & Net Worth: Accounts Payable, Mortgages, Notes, Bonds due in less than 1 Yr., Other Current Liabilities, Loans from Shareholders, Mortgages, Notes, Bonds > 1 Yr., Other Liabilities, Capital Stock, Additional Paid-in Capital, Retained Earnings, Cost of Treasury Stock
37 – Operating Expenses
– Industry Operating Expenses
– Revenue vs. Operating Expense Growth
– Operating Expense as a Percent of Revenue
– Trend Analysis & Forecasts
38 – Operating Expenses by Company & Facility
– Operating Expenses per Company & Facility
– Revenue vs. Expenses Growth per Facility
– Trend Analysis & Forecasts
Page 39 – Operating Expense Detail
– Employee Expenses: Annual Payroll, Health insurance, Defined benefit pension plans, Defined contribution plans, Other fringe benefits, Temporary staff
– Cost of Materials: Cost of materials, parts, containers, packaging, etc., Cost of resale, Cost of electricity and fuels, Cost of contract work
– Buildings and Equipment: Capex for machinery and equipment, Rental or lease for machinery and equipment, Capex for buildings and structures, Rental or lease for buildings and structures, Repair and maintenance of buildings and machinery
– Other Operating Expenses: Professional and technical services, IT software and hardware, Data processing and communications, Advertising, Refuse removal, Taxes and license fees, All other operating expenses
-Inventory Breakdown: Inventory (as a % of total receipts), Finished goods inventory, Work-in-progress inventory, Materials and supplies inventory
40 – Production Material Costs & Tariff Analysis
– Top Production Material Costs Breakdown
– Industry & Material Tariff Analysis – % of costs, import %, tariff costs, source countries
41 – Producer Pricing Index
– Annual PPI – Indexed to 2006
– 2017-2025 Historical Figures
– Forecasts for 2026 and the Next 5 Years
– Monthly PPI Figures for the Past 4 Years
42 – Plant Utilization & Hours
– Plant Utilization Rate
– Plant Operational Hours per Week
– 2022-2025 Historical Figures by Quarter
43 – Reasons for Non-Full Production
– 7 Categories Quarterly Survey Results for Past 2 Years
44 – Productivity & Employment
– Revenue per Employee
– Total Industry Employees
– Employees per Company
– Trend Analysis & Forecasts
45 – Employee Productivity by Segments
46 – Employee Productivity by State
47 – Manufacturing Subsector Sales & Payroll per Employee
– Absolute & 5-year CAGR
48 – Payroll Analysis
– Payroll per Employee, Company & Facility
– Trend Analysis & Forecasts
49 – Payroll per Company by Segments
50 – Payroll per Facility by Segments
51 – Payroll per Employee by Segments
52 – Payroll per Employee by State
53 – Workforce Composition
– % of Employees for 27 Job Categories
– Management & Finance
– Sales & Marketing
– Technology, Engineering, Science
– Service, Support & Training
– Operations
54 – Job Categorization Pay Ranges
– Pay Bands – Bottom 10% & 25%, Mean, Top 25% & 10%
55 – Top 20 Jobs Breakdown
– Percent of Total Employees
56 – Top 20 Jobs Pay
57 – Employees per Company by Segments
58 – Employees per Facility by Segments
59 – Facilities per Company by Segments
60 – Total Employment by State
61 – Population to Every Employee by State
62 – Employees per Facility by State
63 – Overview of Kentley Insights
Download a Sample Report
Below is a free sample report download. The 2026 Biological Product Manufacturing Market Report has the same layout and data sets as the sample report.
Product Lines, Materials, and Jobs Covered in Report
PRODUCT LINES
Other biologics, excluding diagnostic, for human use
Vaccines, toxoids, and antigens, excluding allergens, for human use
Blood and blood derivatives, for human use
Biological products, excluding diagnostic, for veterinary, industrial, and all other miscellaneous uses
Biological product (except diagnostic) manufacturing, nsk, total
MATERIAL COST CATEGORIES
Pharmaceuticals & medicines, including synthetic; medicinal & botanical drugs, chemicals, and products; biological products; etc.
Materials, ingredients, containers, and supplies, nsk
Cost of all other materials and components, parts, containers, and supplies consumed
All basic organic and inorganic chemicals, excluding petrochemicals
Glass and glass products
Plastics containers (including bottles, jars, tubes, tubs, etc.)
INDUSTRY JOBS ANALYZED
Packaging and Filling Machine Operators and Tenders
Chemists and Materials Scientists
Sales Representatives, Wholesale and Manufacturing
Chemical Processing Machine Setters, Operators, and Tenders
Inspectors, Testers, Sorters, Samplers, and Weighers
Crushing, Grinding, Polishing, Mixing, and Blending Workers
First-Line Supervisors of Production and Operating Workers
Medical Scientists
Biological Scientists
Laborers and Material Movers, Hand
Industrial Engineers, Including Health and Safety
Industrial Machinery Installation, Repair, and Maintenance Workers
Chemical Technicians
Industrial Production Managers
Biological Technicians
General and Operations Managers
Natural Sciences Managers
Miscellaneous Business Operations Specialists
Secretaries and Administrative Assistants
Miscellaneous Assemblers and Fabricators
About Kentley Insights
All the top consulting firms, banks, accounting firms, private equity firms, and many of the Fortune 1000 depend on Kentley Insights for their in-depth market research needs.
Purchase the 2026 U.S. Biological Product Manufacturing Market Report to unlock the 63 pages of data-rich insights backed by our 100% MoneyBack Guarantee.
Support Contact:
Email us at support@kentleyinsights.com
Call us at 1-800-613-3611